6
Views
6
CrossRef citations to date
0
Altmetric
Journal Article

Effect of N-3 polyunsaturated fatty acid supplemented diet on neutrophil-mediated ileal permeability and neutrophil function in the rat.

, &
Pages 258-263 | Published online: 04 Sep 2013

References

  • Lorenz R, Weber PC, Szimnau P, Heldwein W, Strasser T, Loe-schke K: Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease-a randomized, placebo controlled double-blind cross-over trial. J Int Med Suppl 225(731):225–232, 1989.
  • O'Morain C, Tobin A, Suzuki Y, O'Riordan T: Risk factors in inflammatory bowel disease. Scand J Gastroenterol 24(Suppl 170):58–60, 1989.
  • Vilaseca J, Salas A, Guarner F, Rodriguez R, Martinez M, Malagelada JR: Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut 31(5):539–544, 1990.
  • Lees R, Karel M: “Omega-3 Fatty Acids in Health and Disease.” New York: Marcel Dekker, Inc., 1990.
  • Dreyling KW, Hoppe V, Peskar BA, Schaarschmidt K, Peskar BM: Leukotrienes in Crohn's disease: effect of sulfasalazine and 5-aminosalicylic acid. In Samuelsonn B, Padett R, Ramwell PW (eds): “Advances in Prostaglandin, Thromboxane, and Leukotriene Research.” New York: Raven Press, pp 339–343, 1987.
  • Wallace JL, Keenan C: Leukotriene B4 potentiates colonic ulceration in the rat. Dig Dis Sci 35(5):622–629, 1990.
  • Scheurlen M, Steinhilber D, Willi D, Clemens M, Schmidt H, Jaschonek K: Effects of an elemental diet containing fish oil on neutrophil LTB4 synthesis and membrane lipid composition. Prog Clin Biol Res 301: 505–509, 1989.
  • Leitch AG, Lee TH, Ringel EW, Prickett JD, Robinson Dr, Pyne SG, Corey EJ, Drazen JM, Austen KF, Lewis RA: Immunologically induced generation of tetraene and pentaene leukotrienes in the peritoneal cavities of menhaden-fed rats. J of Immunol 132(5):2559–2505, 1989.
  • Arm JP, Horton CE, Mencia-Huerta JM, House F, Eiser NM, Clark TJ, Spur BW, Lee TH: Effect of dietary supplementation with fish oil lipids on mild asthma. Thorax 43(2):84–92, 1988.
  • Schmidt EB, Sorensen PJ, Pedersen JO, Jensild C, Ditzel J, Grannet N, Dyerberg J: The effect of N-3 PUFA on lipids, hemostasis, neutrophil and monocyte chemotaxis in insulin-dependent diabetes mellitus. J Int Med Res Suppl I:201–206, 1989.
  • Schmidt EB: Cod liver oil inhibits neutrophil and monocyte chemotaxis in healthy males. Atherosclerosis 77(1):53–57, 1989.
  • Elson CO: The immunology of inflammatory bowel disease. In Kirsner JB, Shorter RG (eds): “Inflammatory Bowel Disease” 3rd ed. Philadelphia: Lea & Febiger, pp 97–164, 1988.
  • MacDermott RP, Stenson WF: Alterations of the immune system in ulcerative colitis and Crohn's disease. Adv Immunol 42: 285–328, 1988.
  • Saverymuttu SH, Peters AM, Lavender JP, Pepys MB, Hodgson HJF, Chadwick VS: Quantitative fecal indium 111-labelled leukocyte excretion in the assessment of disease in Crohn's disease. Gastroenterology 85: 1333–1339, 1983.
  • Grisham MB, Granger DN: Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Dig Dis Sci 33: 6S–15S, 1988.
  • Kitahora T, Suzuki K, Asakura H, Yoshida T, Suematsu M, Watanabe M, Aiso S, Tsuchiya M: Active oxygen species generated by monocytes and polymorphonuclear cells in Crohn's disease. Dig Dis Sci 33(8):951–955, 1988.
  • Von Ritter C, Grisham MB, Granger DN: Formyl-methionyl-leucyl-phenylalanine induced mucosal injury in rat ileum. Gastroenterology 96: 811–816, 1989.
  • Grisham MB, Gaginella TS, Von Ritter C, Tamai H, Be RM, Granger DN: Effects of neutrophil-derived oxidants on intestinal permeability, electrolyte transport, and epithelial cell viability. Inflammation 14(5):531–542, 1990.
  • Lobos EA, Sharon P, Stenson WF: Chemotactic activity in inflammatory bowel disease: role of leukotriene B4. Dig Dis Sci 32(12):1380–1388, 1987.
  • Hollander D, Vadheim CM, Brettholtz E, Peterson GM, Delahunty TJ, Rotter JI: Increased intestinal permeability in patients with Crohn's disease and their relatives. Ann Intern Med 105: 883–885, 1986.
  • Pearson AD, Easthan EJ, Laker MF, Craft AW, Nelson R: Intestinal permeability in children with Crohn disease and coeliac disease. Br Med J 285: 20–21, 1982.
  • Bjarhason I, O'Morian C, Levi AJ, Peters TJ: Absorption of 51-chromium-labelled ethylenediaminetetracetate in inflammatory bowel disease. Gastroenterology August;85(2):318–322, 1983.
  • Ukabam SO, Clamp JR, Cooper BT: Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon. Digestion 27: 70–74, 1983.
  • Fagundes-Neto U, Teichberg S, Bayne MA, Morton B, Lifshitz F: Bile salt enhanced rat jejunal absorption of macromolecule. Lab Invest 44: 18–26, 1981.
  • Yuan Y, Fleming BP: A method for isolation and fluorescent labeling of rat neutrophils for intravital microvascular studies. Microvas Res 40: 218–229, 1990.
  • Boyden S: The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leukocytes. J Exp Med 115: 453–466, 1962.
  • Campbell AK, Mallett MB, Weeks I: Chemiluminescence as analytical tool in cell biology and medicine. Methods Biochem Anal 31: 317–415, 1985.
  • Williams JA, Hughes LE, Mallet MB: Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease. Gut 31: 187–193, 1990.
  • Stevens P, Winston DJ, Van Dyke K: In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: utility in patients with severe neutropenia and cellular deficiency states. Infect Immun 22: 41–51, 1978.
  • Hawkey C, Gassull M, Lauritsen K, Martin F, O'Morain C, Rask-Madsen J, Wright J, Dube L, Rountree L, Broutman L: Efficacy of Zileuton, A5-Lipoxygenase inhibitor, in the maintenance of remission in patients with ulcerative colitis. (Abstract). Gastroenterology 106: A697, 1994.
  • Stenson WF, Cort D, Rodgers J, Burakoff R, DeSchryver-Keeskemeti K, Gramlich TL, Beeken W: Dietary supplementation with fish oil in ulcerative colitis. Ann Int Med 116: 609–614, 1992.
  • Cleland LG, James MJ, Gibson RA, Hawkes JS, Betts WH: Effects of dietary oils on production of N-3 and N-6 metabolites of leukocyte 5 liponygenase in five rat strains. Biochem Biophys Acta 1043(3):253–258, 1990.
  • Von Ritter C, Grisham MB, Granger DN: Sulfasalazine metabolites and Dapsone attenuate formyl-methionyl-leucyl-phenylala-nine induced mucosal injury in rat ileum. Gastroenterology 96: 811–816, 1989.
  • Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese JR, Spur BW, Robinson DR, Corey EJ, Lewis RA, Austen KF: Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 312: 1217–1224, 1985.
  • Anton PA, Targan SR, Shanahan F: Increased neutrophil receptors for a response to the proinflammatory bacterial peptide formyl-methionyl-leucyl-phenylalanine in Crohn's disease. Gastroenterology 97: 20–28, 1989.
  • Ford-Hutchinson AW, Charleson S, Evans JF: Leukotriene B4 receptors on rat and human neutrophil membranes. Methods Enzymol 163: 340–343, 1988.
  • Forman HJ: Inhibition of linoleic acid hydroperoxide of alveloar macrophage superoxide production: effects upon mitochondrial and plasma membrane potentials. Arch Biochem Biophys 274: 443–452, 1989.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.